Skip to content

Athagoras Expands in Life Sciences With Two Strategic Acquisitions

A bold move reshapes the life sciences landscape. Athagoras merges expertise in pricing, EU HTA, and real-world evidence to dominate market access strategies.

The image shows an old German stock certificate issued by Kaiser-Keller Aktiengesellschaft, with...
The image shows an old German stock certificate issued by Kaiser-Keller Aktiengesellschaft, with text and stamps on it.

Athagoras Expands in Life Sciences With Two Strategic Acquisitions

Athagoras, a Munich-based life sciences service provider, has acquired two firms: Ecker + Ecker GmbH and Accessus Health GmbH. The deal strengthens its position in clinical assessments and market access strategies. Legal advice for the sellers was provided by Latham & Watkins. The transaction brings together Ecker + Ecker’s expertise in AMNOG, pricing, and EU Health Technology Assessment with Athagoras’s focus on market access, health economics, and real-world evidence. The merged entity plans to expand its leadership in joint clinical assessments and position itself as the preferred partner for multinational market access.

Latham & Watkins led the legal process for the sellers. Henning Schneider headed the team, with Jacob Fontaine as joint lead. Other team members included Florian BrĂŒggen, Astrid Preuss, Jana MauĂ©, Tobias Klaas, Henning Kleymann, Jana Dammann de Chapto, and Martina Hölzer. As part of the changes, Thomas Ecker stepped down from his role as managing director of Ecker + Ecker Group. Janine Leismann has now taken over as the sole managing director of the company.

The acquisition combines the strengths of three firms under the Athagoras brand. The expanded company will focus on enhancing its services in clinical assessments and global market access. The deal marks a significant step in consolidating expertise within the life sciences sector.

Read also: